Skip to main navigation Skip to search Skip to main content

A non-isotopic in vitro assay for histone acetylation

  • David Kuninger
  • , James Lundblad
  • , Anthony Semirale
  • , Peter Rotwein

Research output: Contribution to journalArticlepeer-review

Abstract

We describe a simple, robust, and relatively inexpensive non-radioactive in vitro assay for measuring histone acetyl-transferase activity. The assay takes advantage of easy to purify recombinant E. coli-derived fusion proteins containing the NH2-terminal tails of histones H3 and H4 linked to epitope-tagged maltose-binding protein (MBP), and immunoblotting with antibodies specific to acetylated H3 and H4. Here we show the specificity and dynamic range of this assay for the histone acetyl-transferases, p300 and PCAF. This assay may be adapted readily for other substrates by simply generating new fusion proteins and for other acetyl-transferases by modifying reaction conditions.

Original languageEnglish (US)
Pages (from-to)253-260
Number of pages8
JournalJournal of Biotechnology
Volume131
Issue number3
DOIs
StatePublished - Sep 15 2007
Externally publishedYes

Funding

These studies were supported by NIH Grants RO1 DK42748 and RO1 DK63073 (to P.R.). We thank Ryan Kuzmickas for technical assistance during the early phases of this project.

FundersFunder number
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of HealthRO1 DK63073, RO1 DK42748
National Institute of Diabetes and Digestive and Kidney DiseasesT32DK007674

    Keywords

    • Acetyl-transferase assay
    • Histone H3
    • Histone H4
    • Non-isotopic
    • PCAF
    • p300

    ASJC Scopus subject areas

    • Biotechnology
    • Bioengineering
    • Applied Microbiology and Biotechnology

    Fingerprint

    Dive into the research topics of 'A non-isotopic in vitro assay for histone acetylation'. Together they form a unique fingerprint.

    Cite this